Jacobs Levy Equity Management, Inc Acrivon Therapeutics, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $24.2 Billion
- Q2 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 382,234 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
382,234Holding current value
$0% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding ACRV
# of Institutions
54Shares Held
18.5MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA8.34MShares$00.0% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA2.12MShares$00.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.9MShares$00.0% of portfolio
-
Wellington Management Group LLP Boston, MA888KShares$00.0% of portfolio
-
Black Rock Inc. New York, NY767KShares$00.0% of portfolio